Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays

被引:36
|
作者
Chovan, LE [1 ]
Black-Schaefer, C [1 ]
Dandliker, PJ [1 ]
Lau, YY [1 ]
机构
[1] Abbott Labs, Adv Technol Dept, Global Pharmaceut Res & Dev, Dept R4CP, N Chicago, IL 60064 USA
关键词
D O I
10.1002/rcm.1735
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
High-throughput metabolic screening has been requested routinely to keep pace with high-throughput organic synthesis. Liquid chromatography/tandem mass spectrometry (LC/MS/MS) with a fast gradient has become the method of choice for the task due to its sensitivity and selectivity. We have developed an automated system that consists of a robotic system for in vitro incubation and a commercially available software package for automatic MS/MS method development. A short, generic LC gradient and MS conditions that are applicable to most compounds have been developed to minimize the method development time and data analysis. This system has been used to support a number of in vitro screening assays in early drug discovery phase including microsomal stability and protein binding. Copyright (C) 2004 John Wiley Sons, Ltd.
引用
收藏
页码:3105 / 3112
页数:8
相关论文
共 50 条
  • [31] Hydrogen deuterium mass spectrometry in drug discovery
    Campobasso, Nino
    Huddler, Donald
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (18) : 3771 - 3776
  • [32] Mass Spectrometry Imaging in Oncology Drug Discovery
    Goodwin, R. J. A.
    Bunch, J.
    McGinnity, D. F.
    APPLICATIONS OF MASS SPECTROMETRY IMAGING TO CANCER, 2017, 134 : 133 - 171
  • [33] Editorial: Microfluidics and mass spectrometry in drug discovery and development: from synthesis to evaluation
    Caruso, Giuseppe
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [34] Advances in Mass Spectrometry Within Drug Discovery
    Wingfield, Jonathan
    Wilson, Ian D.
    JOURNAL OF BIOMOLECULAR SCREENING, 2016, 21 (02) : 109 - 110
  • [35] Development of a low volume plasma sample precipitation procedure for liquid chromatography/tandem mass spectrometry assays used for drug discovery applications
    Xu, XY
    Zhou, Q
    Korfmacher, WA
    RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2005, 19 (15) : 2131 - 2136
  • [36] Application of Mass Spectrometry and Chromatography–Mass Spectrometry in Drug Analysis
    N. A. Klyuev
    Journal of Analytical Chemistry, 2002, 57 : 462 - 479
  • [37] Metabolic engineering for drug discovery and development
    Chaitan Khosla
    Jay D. Keasling
    Nature Reviews Drug Discovery, 2003, 2 : 1019 - 1025
  • [38] Development and application of high throughput plasma stability assay for drug discovery
    Di, L
    Kerns, EH
    Hong, Y
    Chen, H
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 297 (1-2) : 110 - 119
  • [39] Drug discovery and metabolic profiling of combinatorial libraries using pulsed ultrafiltration mass spectrometry.
    van Breemen, RB
    Nikolic, D
    Fan, P
    Bolton, JL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U204 - U204
  • [40] Updated Progress on Mass Spectrometry Imaging and its Application in Cancer Treatment and Drug Discovery
    Li, Mingyue
    Zhou, Jingna
    Zhang, Tingting
    Lu, Jingyang
    Wang, Yajie
    Liu, Junyu
    Zhang, Xiaoyu
    Chen, Haixia
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024,